{{drugbox
| image = Alfentanil.png
| IUPAC_name = ''N''-[1-[2-(4-ethyl-5-oxo-1,4-dihydrotetrazol-1-yl)ethyl]-<br />4-(methoxymethyl)-4-piperidyl]-''N''-phenyl-propanamide
| CAS_number = 71195-58-9
| ATC_prefix = N01
| ATC_suffix = AH02
| PubChem = 51263
| smiles = CCC(=O)N(c1ccccc1)C3(COC)CCN(CCn2nnn(CC)c2=O)CC3
| DrugBank = APRD00726
| C = 21 | H = 32 | N = 6 | O = 3
| molecular_weight = 416.517 g/mol
| melting_point = 140.8
| bioavailability = 100%
| protein_bound = 92%
| metabolism = Hepatic
| elimination_half-life = 90–111 minutes
| legal_US = Schedule II
| legal_UK          = Class A
| routes_of_administration = Intravenous
}}
'''Alfentanil''' (trade name '''Alfenta''') is a potent but short-acting synthetic drug, used for anaesthesia in surgery.  It is an analogue of fentanyl with around 1/4 the potency of fentanyl and around 1/3 of the duration of action, but with an onset of effects 4x faster than fentanyl.<ref>[http://www.google.com/patents?id=msJ_AAAAEBAJ&dq=7208604 Jacob Mathew, J. Kendall Killgore. Methods for the synthesis of alfentanil, sufentanil, and remifentanil. US Patent 7,208,604]</ref> It is an OP3 mu-agonist.

While alfentanil tends to cause less cardiovascular complications than other similar drugs such as fentanyl and remifentanil it tends to give stronger respiratory depression and so requires careful monitoring of breathing and vital signs. Alfentanil is administered by the parenteral (injected) route for fast onset of effects and precise control of dosage.

Alfentanil is a restricted drug which is classified as U.S. DEA website.<ref name="http://www.deadiversion.usdoj.gov/schedules/listby_sched/sched2.htm">[http://www.deadiversion.usdoj.gov/schedules/listby_sched/sched2.htm From DEA website, accessed 23 Jan 2007]</ref>

Alfentanil was discovered at Janssen Pharmaceutica in 1976.

{{Pharmacologie
|nom = Alfentanil
|nom_IUPAC = ''N''-[1-[2-(4-éthyl-5-oxo-1,4-dihydrotétrazol-1-yl)éthyl]-<br />4-(méthoxyméthyl)-4-pipéridyl]-''N''-phényl-propanamide
|image = Alfentanil.png
|numéro_CAS = 71195-58-9
|préfixe_ATC = N01
|suffixe_ATC = AH02
| PubChem = 189496
| formule_brute = C<sub>21</sub>H<sub>32</sub>N<sub>6</sub>O<sub>3
| masse_moléculaire = 416.517 g/mol
| biodisponibilité = 100 % (IV)
| métabolisme = Hépatique
| demi-vie_d'élimination = 90 à 111 minutes
| excrétion = 
| classe_thérapeutique = Analgésique opioïde&nbsp;•&nbsp;Stupéfiant
| voie_d'administration = Intraveineuse
| pKa = 6,5
| précautions = Dépresseur respiratoire
| risque_dépendance = Très élevé si usage<br />non-thérapeutique
| catégorie_psychotrope = Stupéfiant
}}
L''''alfentanil''' est un analgésique majeur synthétique dérivé de la morphine utilisé en anesthésie sous forme de chlorhydrate d'alfentanil (Rapifen ®). Son délai d'action court et son élimination rapide le rendent intéressant pour les chirurgies de courte durée. Il a été synthétisé pour la première fois en 1976.

Catégorie:Drogue anesthésique
Catégorie:Analgésique